Advertisement

Urticaria and Angioedema

  • Albert F. FinnJr.
Chapter
  • 111 Downloads
Part of the Current Clinical Practice book series (CCP)

Abstract

Patients exhibiting hives and associated soft tissue swelling are common in the outpatient setting. These complaints brought to the primary care physician generally will result in a diagnosis of urticaria and angioedema. The patients refer to the urticaria and angioedema by various descriptive terms, such as hives, welts or an itchy rash. Indeed, the lesions that are described by patients with a variety of terms can have a diverse appearance. Categorically, urticarial lesions are pruritic and have a center portion that is elevated. The elevated center is often surrounded by an erythematous halo. This prototypical lesion morphologically has a central wheal with a surrounding flare. However, the configuration of the lesions can be quite different, with some lesions typically being round and circumscribed, while others can be serpiginous or diffuse. Characteristically, the lesions should blanch with pressure, and they generally resolve within 24 h, leaving no residual change to the skin. Lesions that do not blanch, result in pigmentation or scarring of the skin, or are not pruritic should be assessed for other dermatological processes or vasculitis.

Keywords

Mast Cell Chronic Urticaria Mast Cell Degranulation Chronic Idiopathic Urticaria Acute Urticaria 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Suggested Reading

  1. Alam R Chemokines in allergic inflammation. JAllergy Clin Immunol 1997; 99: 273–277.CrossRefGoogle Scholar
  2. Dayan CM, Daniels GH. Chronic autoimmune thyroiditis. N Engl J Med 1996; 335: 99–107.PubMedCrossRefGoogle Scholar
  3. Finn A, Kaplan AP, Fretwell R, Qu R, Long J. A double-blind, placebo-controlled trial of fexofenadine HC1 in the treatment of chronic idiopathic urticaria (CIU). J Allergy Clin Immunol 1999; 103: 1071–1078.CrossRefGoogle Scholar
  4. Hide M, Francis DM, Grattan CEH, et al. Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med 1993; 328: 1599–1604.PubMedCrossRefGoogle Scholar
  5. Kaplan, AP. Urticaria and angioedema. In: Allergy. Philadelphia; WB Saunders, 1997, pp. 573–592.Google Scholar
  6. Monroe EW. Nonsedating H1 antihistamines in chronic urticaria. Ann. Allergy 1993; 71: 585–591.PubMedGoogle Scholar
  7. Monroe, EW, Fox RW, Green AW. Efficacy and safety of loratadine in the management of idiopathic chronic urticaria. JAm Acad Dermatol 1998; 19: 138–139.CrossRefGoogle Scholar
  8. O’Donnell BF, Lawlor F, Simpson J, et al. The impact of chronic urticaria on the quality of life. Br J Dermatol 1997; 136: 197–201.PubMedCrossRefGoogle Scholar
  9. Paradis L, Lavoic A, Brunet C, et al. Effects of systemic corticosteroids on cutaneous histamine secretion and histamine-releasing factor in patients with chronic idiopathic urticaria. Clin Exp Allergy 1996; 25: 815–820.CrossRefGoogle Scholar
  10. Pierson WE. Cetirizine: A unique second-generation antihistamine for treatment of rhinitis and chronic urticaria. Clin Ther 1991; 13: 92–99.PubMedGoogle Scholar
  11. Soter NA. Acute and chronic urticaria and angioedema. JAm Acad Dermatol 1991; 25: 146–154.CrossRefGoogle Scholar
  12. Tong, LF, Balakrishan G, Kochan JP, et al. Assessment of autoimmunity in chronic urticaria. J Allergy Clin Immunol 1997; 99: 461–465.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2000

Authors and Affiliations

  • Albert F. FinnJr.

There are no affiliations available

Personalised recommendations